LIKARDA LLC

Kansas City, KS · Biotech · Private

Encapsulated insulin-producing pluripotent stem cells using proprietary microplates and biocompatible hydrogel technology for diabetes treatment

likarda.com →
Grants
$513K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
11
1 granted · 10 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Clinical grade insulin-producing iPSCs encapsulated with durable hyaluronic acid for long-term treatment of type 1 diabetes$256,338
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Clinical grade insulin-producing iPSCs encapsulated with durable hyaluronic acid for long-term treatment of type 1 diabetes$256,338
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1983POP ART, INC.—$1.0M
1984NEURAEGIS INC——
1985C4 Therapeutics—$70M
1986LIKARDA LLC——
1987NATURA THERAPEUTICS, INC.——
1988Ultimaxx Health, LLC—$10M
1989LIGHT SWITCH BIO, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 11
  • Hydrogel Microparticle-based Soft Tissue Fillersapplication
  • Hydrogel Microparticle-based Lubricantapplication
  • Microencapsulation Technique And Products Thereofgranted
  • Hydrogel Microparticle-based Lubricantapplication
  • Hydrogel Microparticle-based Lubricantapplication
  • Tunable Degradation In Hydrogel Microparticlesapplication
  • Tunable Degradation In Hydrogel Microparticlesapplication
  • Microencapsulation Technique And Products Thereofapplication
  • Microencapsulation Technique And Products Thereofapplication
  • Hydrogel Microparticle-based Soft Tissue Fillersapplication
  • Hydrogel Microparticle-based Dermal Fillersapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.